Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Signs on Four Payors

NEW YORK (GenomeWeb News) – Response Genetics today said it has signed agreements with four payors to provide access to the molecular diagnostic firm's tests.

The deals are with America's Choice Provider Network, FedMed, Galaxy Health Network, and Prime Health Services, and increases the number of people in the US who now have access to Response's tests by 54 million, the company said. It added that in 2013, it has entered into a total of six PPO network contracts providing access to its tests to more than 135 million Americans.

Los Angeles-based Response offers genomic testing focused on lung, colon, and gastric cancer, as well as melanoma. The tests are used by physicians to help guide them in choosing therapeutic treatments for their patients.

Last week, the company reported that revenues in its third quarter decreased 24 percent year over year to $4.1 million.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.